drugset

drugset / Trial / NCT00002022

Treatment Program for Anemia in AIDS Patients

NCT00002022 ↗

Completed R W Johnson Pharmaceutical Research Institute

Treatment

Summary

The objective of the Eprex (erythropoietin) Treatment Program is to provide erythropoietin for the treatment of anemia in AIDS patients.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	epoetin alfa	Protein / enzyme biologic	—	—

Indications